Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty
- PMID: 34493344
- PMCID: PMC8425132
- DOI: 10.1186/s43019-021-00109-z
Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty
Abstract
Background: With an increase in deep vein thrombosis (DVT) following total knee arthroplasty (TKA) in the Asian population, most surgeons today use a form of prophylactic anticoagulant agents in patients after TKA. Nevertheless, DVT occasionally develops even in these patients with prophylaxis. The purpose of this study was to identify the risk factors for DVT after TKA in cases of postoperative low-molecular-weight heparin (LMWH) use.
Methods: We designed a retrospective study with 103 patients who underwent primary TKA. From the second postoperative day, 60 mg of LMWH was subcutaneously injected into the patients daily. On the seventh postoperative day, patients had computed tomography angiography to check whether they had DVT. Regarding risk factors, we investigated patients' gender, age, surgical site (unilateral/bilateral), body mass index, method of anesthesia, preoperative hypertension, diabetes, hypercholesterolemia status, and prothrombin time/international normalized ratio from electronic medical records. We analyzed the statistical significance of these risk factors.
Results: Statistically significant factors in the single-variable analysis were surgical site (unilateral/bilateral), body mass index, preoperative hypertension status, and anesthesia method. Multiple logistic regression analysis with these factors revealed that the surgical site (unilateral/bilateral, p = 0.024) and anesthesia method (p = 0.039) were significant factors for the occurrence of postoperative DVT after TKA.
Conclusions: Patients undergoing simultaneous bilateral TKAs and patients undergoing TKA with general anesthesia need more attention regarding DVT even with chemoprophylaxis using LMWH after TKA.
Keywords: Anticoagulant agent; Deep vein thrombosis; Low-molecular-weight-heparin; Risk factor; Total knee arthroplasty.
© 2021. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
References
-
- Piovella F, Wang CJ, Lu H, Lee K, Lee LH, Lee WC, et al. Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography. J Thromb Haemost. 2005;3(12):2664–2670. doi: 10.1111/j.1538-7836.2005.01621.x. - DOI - PubMed
-
- Harrison-Brown M, Scholes C, Douglas SL, Farah SB, Kerr D, Kohan L. Multimodal thromboprophylaxis in low-risk patients undergoing lower limb arthroplasty: a retrospective observational cohort analysis of 1400 patients with ultrasound screening. J Orthop Surg (Hong Kong) 2020;28(2):2309499020926790. doi: 10.1177/2309499020926790. - DOI - PubMed
-
- Park SH, Ahn JH, Park YB, Lee SG, Yim SJ. Incidences of deep vein thrombosis and pulmonary embolism after total knee arthroplasty using a mechanical compression device with and without low-molecular-weight heparin. Knee Surg Relat Res. 2016;28(3):213–218. doi: 10.5792/ksrr.2016.28.3.213. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
